LSL Pharma Group Inc. (TSXV:LSL)
0.3500
-0.0050 (-1.41%)
At close: Aug 10, 2026
-14.63% (1Y)
| Market Cap | 44.99M -6.2% |
| Revenue (ttm) | 28.74M +62.0% |
| Net Income | -2.82M |
| EPS | -0.02 |
| Shares Out | 126.73M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,000 |
| Open | 0.3500 |
| Previous Close | 0.3550 |
| Day's Range | 0.3400 - 0.3500 |
| 52-Week Range | 0.3000 - 0.5600 |
| Beta | -0.49 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 28, 2026 |